Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters
Authors
Keywords
[<sup>18</sup>F]FDG, <sup>31</sup>P-NMR, Trastuzumab, Hexokinase, Xenograft
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 71, Issue 2, Pages 473-480
Publisher
Springer Nature
Online
2012-11-23
DOI
10.1007/s00280-012-2032-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PET/MRI and the revolution of the third eye
- (2012) Luigi Mansi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Early [18F]Fluorodeoxyglucose Positron Emission Tomography at Two Days of Gefitinib Treatment Predicts Clinical Outcome in Patients with Adenocarcinoma of the Lung
- (2011) R. Takahashi et al. CLINICAL CANCER RESEARCH
- Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non-Small Cell Lung Cancer Treated with Erlotinib
- (2011) L. Mileshkin et al. CLINICAL CANCER RESEARCH
- Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study
- (2011) Ningyan Zhang et al. mAbs
- Quantitative 31P magnetic resonance spectroscopy of the human breast at 7 T
- (2011) Jannie P. Wijnen et al. MAGNETIC RESONANCE IN MEDICINE
- A systematic review of PET and PET/CT in oncology: A way to personalize cancer treatment in a cost-effective manner?
- (2010) Astrid Langer BMC HEALTH SERVICES RESEARCH
- The Phosphoinositide 3-Kinase Inhibitor PI-103 Downregulates Choline Kinase Leading to Phosphocholine and Total Choline Decrease Detected by Magnetic Resonance Spectroscopy
- (2010) N. M. S. Al-Saffar et al. CANCER RESEARCH
- HER2 assessment on core biopsy specimens using monoclonal antibody CB11 accurately determines HER2 status in breast carcinoma
- (2010) Colin A Purdie et al. HISTOPATHOLOGY
- Changes in 2-fluoro-2-deoxy-d-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumab
- (2010) Richard W. Cheyne et al. NUCLEAR MEDICINE AND BIOLOGY
- Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
- (2009) S. J. Aitken et al. ANNALS OF ONCOLOGY
- Systems Biology Reveals New Strategies for Personalizing Cancer Medicine and Confirms the Role of PTEN in Resistance to Trastuzumab
- (2009) D. Faratian et al. CANCER RESEARCH
- Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer
- (2009) C. Shah et al. CLINICAL CANCER RESEARCH
- 18F-FDG Small-Animal PET/CT Differentiates Trastuzumab-Responsive from Unresponsive Human Breast Cancer Xenografts in Athymic Mice
- (2009) K. McLarty et al. JOURNAL OF NUCLEAR MEDICINE
- Fibronectin Stimulates Endothelial Cell 18F-FDG Uptake Through Focal Adhesion Kinase-Mediated Phosphatidylinositol 3-Kinase/Akt Signaling
- (2009) J.-Y. Paik et al. JOURNAL OF NUCLEAR MEDICINE
- Tumor Metabolism and Blood Flow Changes by Positron Emission Tomography: Relation to Survival in Patients Treated With Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
- (2008) Lisa K. Dunnwald et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour glycolysis: The many faces of HIF
- (2008) Catherine Kelly et al. JOURNAL OF THEORETICAL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now